Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer.
Wei-Chi LuoShi-Qi MeiZi-Jian HuangZhi-Hong ChenYi-Chen ZhangMing-Yi YangJia-Qi LiuJing-Yan XuXiao-Rong YangRi-Wei ZhongLi-Bo TangLin-Xi YinYu DengYing-Long PengChang LuBao-Long ChenDong-Xian KeHai-Yan TuJin-Ji YangChong-Rui XuYi-Long WuQing ZhouPublished in: Journal of translational medicine (2024)
The use of antibiotics weakens immunotherapy efficacy in patients with advanced EGFR + NSCLC. The distribution characteristics and dynamic changes of gut microbiota and metabolites may indicate the efficacy of immunotherapy in advanced EGFR + NSCLC.